Literature DB >> 6169822

Enteric transport of chlordecone (Kepone) in the rat.

P M Bungay, R L Dedrick, H B Matthews.   

Abstract

Disposition of chlordecone (Kepone) in the rat is quantitated. Particular attention is devoted to the role of the intestinal tract in excretion, as well as absorption, of the parent form of the halogenated pesticide. A detailed physiological pharmacokinetic model for the GI tract is presented in which the organs are segmented into a series of well-mixed compartments representing stomach, small intestine, cecum, and large intestine. The model is applied to the early time behavior of data from the following two types of studies in the rat: (1) the movement of a nonabsorbable tracer along the GI tract, and (2) the enteric transport of parent chlordecone. Model parameter values for the gut wall permeability-area products for parent chlordecone determined for the rat are used to estimate the corresponding values for man based on scale-up considerations. The enhancement of excretion rates through use of orally administered adsorbents is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169822     DOI: 10.1007/BF01059269

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  16 in total

1.  A new therapeutic approach to unconjugated hyperbilirubinaemia.

Authors:  R LESTER; L HAMMAKER; R SCHMID
Journal:  Lancet       Date:  1962-12-15       Impact factor: 79.321

2.  Irradiation of the gastrointestinal tract of the rat by ingested ruthenium-106.

Authors:  R C THOMPSON; O L HOLLIS
Journal:  Am J Physiol       Date:  1958-08

3.  Pituitary receptor binding assay of hypothalamic releasing factors.

Authors:  G Grant; W Vale
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

4.  Energy metabolism, body size, and problems of scaling.

Authors:  K Schmidt-Nielsen
Journal:  Fed Proc       Date:  1970 Jul-Aug

5.  GI drug absorption in rats exposed to cobalt-60 gamma-radiation II: in vivo rate of absorption.

Authors:  M E Brady; W L Hayton
Journal:  J Pharm Sci       Date:  1977-03       Impact factor: 3.534

6.  Pharmacokinetics of halogenated hydrocarbons.

Authors:  P M Bungay; R L Dedrick; H B Matthews
Journal:  Ann N Y Acad Sci       Date:  1979-05-31       Impact factor: 5.691

7.  The distribution and excretion of 2,4,5,2',5'-pentachlorobiphenyl in the rat.

Authors:  H B Matthews; M W Anderson
Journal:  Drug Metab Dispos       Date:  1975 May-Jun       Impact factor: 3.922

8.  Excretion of chlordecone by the gastrointestinal tract: evidence for a nonbiliary mechanism.

Authors:  J J Boylan; W J Cohn; J L Egle; R V Blanke; P S Guzelian
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

9.  Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial.

Authors:  W J Cohn; J J Boylan; R V Blanke; M W Fariss; J R Howell; P S Guzelian
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

10.  Distribution and excretion of chlordecone (Kepone) in the rat.

Authors:  J L Egle; J B Fernandez; P S Guzelian; J F Borzelleca
Journal:  Drug Metab Dispos       Date:  1978 Jan-Feb       Impact factor: 3.922

View more
  4 in total

1.  Chlorinated paraffins: disposition of a highly chlorinated polychlorohexadecane in mice and quail.

Authors:  A Biessmann; P O Darnerud; I Brandt
Journal:  Arch Toxicol       Date:  1983-05       Impact factor: 5.153

2.  The pharmacokinetics of chlortetracycline orally administered to turkeys: influence of citric acid and Pasteurella multocida infection.

Authors:  R A Pollet; C E Glatz; D C Dyer
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

3.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

4.  Chlordecone: development of a physiologically based pharmacokinetic tool to support human health risks assessments.

Authors:  Claude Emond; Luc Multigner
Journal:  Arch Toxicol       Date:  2022-02-05       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.